Reported about 2 months ago
Nestle chairman Paul Bulcke stated in an interview that the company plans to retain its Health Science unit despite the recent departure of CEO Mark Schneider. Bulcke emphasized the promising prospects of the health sector, contrasting with analysts' speculations that the unit could be sold in the medium term. This announcement comes amid a challenging period for Nestle, marked by declining share prices and performance issues since May 2023.
Source: YAHOO